Amarin raises $200M ahead of Vascepa push

Amarin raises $200M ahead of Vascepa push

Source: 
BioCentury
News Tags: 
snippet: 

Amarin Corp. plc (NASDAQ:AMRN) raised $200 million in a follow-on late Monday as it prepares to add cardioprotective data to the label of omega-3 therapy Vascepa icosapent ethyl following a readout from the Phase III REDUCE-IT trial.